Clinical Trial Update: Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether N-acetylcysteine affects creatinine levels in chronic kidney disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Chronic Kidney Disease | Phase 3 | Status: COMPLETED